DELCATH SYSTEMS, INC. Deferred Income Tax Expense (Benefit)
DELCATH SYSTEMS, INC. (DCTH) reported Deferred Income Tax Expense (Benefit) of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-02-26
- DELCATH SYSTEMS, INC. deferred income tax expense (benefit) for fiscal 2025 was $0.00.
- DELCATH SYSTEMS, INC. deferred income tax expense (benefit) for fiscal 2024 was $0.00.
| Period end | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| CARLSMED, INC. (CARL) | United States | $0.405B |